Summary
Cencora, Inc. (formerly AmerisourceBergen Corporation) filed an 8-K on December 8, 2014, to report a material definitive agreement. Specifically, the company entered into the Eighth Amendment to its Amended and Restated Receivables Purchase Agreement on December 5, 2014. This amendment is significant as it impacts the company's liquidity and funding mechanisms, particularly through its securitization facility. The primary purpose of this amendment is to enhance the flexibility and extend the operational parameters of the receivables purchase facility. Key adjustments include extending the time period for Days Sales Outstanding (DSO) before an Amortization Event is triggered, increasing the allowable percentage of Eligible Receivables under the Obligor Concentration Limit, and extending the termination date of the facility. These changes are designed to support ongoing business needs and potentially seasonal funding requirements.
Key Highlights
- 1AmerisourceBergen Corporation (now Cencora, Inc.) executed an Eighth Amendment to its Amended and Restated Receivables Purchase Agreement on December 5, 2014.
- 2The amendment enhances the company's liquidity and funding capabilities through a securitization facility.
- 3Key changes include extending the DSO threshold for an Amortization Event, increasing the Obligor Concentration Limit, and extending the facility's termination date.
- 4The securitization facility is based on accounts receivables from pharmaceutical sales and related services.
- 5The facility has a base limit of $950 million with an option to increase by an additional $250 million for seasonal needs.
- 6The company's ongoing business needs are supported by this agreement.
- 7The filing was signed by Tim G. Guttman, Executive Vice President and Chief Financial Officer.